Delly Ramadon is an associate professor in transdermal/intradermal drug delivery system and head of the Pharmaceutics and Pharmaceutical Technology Laboratory at the Faculty of Pharmacy, Universitas Indonesia. He obtained his PhD degree from the School of Pharmacy, Queen’s University Belfast, UK, in 2020. His research is focused on transdermal/intradermal drug delivery system using various kinds of enhancement strategies, including permeation enhancers, nanoparticles, nanovesicles, and polymeric microneedles. His research has been supported by research grants from Universitas Indonesia; the Ministry of Higher Education, Science, and Technology, Republic of Indonesia; the National Research and Innovation Agency (BRIN) of Indonesia; and overseas pharmaceutical companies. In 2022, he has served as a Postdoctoral Research Fellow at Daewoong Pharmaceuticals, South Korea. He was also invited as a Visiting Scholar in the Global Excellence in Pharmacy program at Ulster University in 2024 funded by the International Science Partnerships Fund, Department for the Economy, Northern Ireland.

Zi (Sophia) Gu is an Associate Professor in the School of Chemical Engineering at the University of New South Wales (UNSW Sydney), where she leads the NanoBiotechnology Research Group. She is a Chief Investigator at the ARC Centre of Excellence for Carbon Science & Innovation, and a member of both the Australian Centre for NanoMedicine and the UNSW RNA Institute. After completing her PhD training at the University of Queensland and Cornell University, she was awarded an NHMRC Fellowship and joined UNSW in 2016. Her research focuses on the design of advanced nanomaterials and delivery strategies to tackle challenges in medicine and health. To date, she has published over 90 peer-reviewed papers in nanomaterials and nanomedicine. She currently serves as Editor-in-Chief of Cancer Nanotechnology and as Associate Editor for the Journal of Nanobiotechnology and Exploration.

Nguyen Thi Oanh Oanh graduated with a bachelor's degree from Hanoi University of Pharmacy, Vietnam. She is currently pursuing her PhD at the College of Pharmacy, Yeungnam University, Korea. Her primary research focus is on drug delivery systems and their applications in anti-aging treatments.

Dr. Priyadarshini Mohapatra is a nanomedicine researcher with expertise in biomaterials, drug delivery, and targeted cancer therapy. She completed her Ph.D. in Nanomedicne/Biomedical Science at Vellore Institute of Technology under ICMR funding, focusing on core-shell nanoformulations targeting the Wnt/β-catenin pathway in liver cancer. She has served as a Senior Research Fellow at ICMR and held a postdoctoral position at Alliance University, Bengaluru. With over seven peer-reviewed publications and presentations at six national and international conferences, she has also received the Trialect Fellowship and contributed as a reviewer for reputed journals.

He graduated from the Faculty of Pharmaceutical Sciences at Tokyo University of Science in 2024 and entered the Maser course at the Graduate School of Pharmaceutical Sciences at the same university in the same year. He is currently a second-year student in the Laboratory of Biopharmaceutics. He has received several awards, including the Student Oral Presentation Awards at the 144th (2024) and 145th (2025) Annual Meeting of the Pharmaceutical Society of Japan, as well as the Best Presenter Award at the 40th Annual Meeting of the Academy of Pharmaceutical Science and Technology, Japan (2025).